A groundbreaking clinical trial at City of Hope may redefine stem cell transplants by reducing GVHD risk and expanding donor access for blood cancer patients.
Nick DeGraw
Subscribe to our CancerCenter Newsletter
Thank you
Keep an eye on your inbox for the latest City of Hope news and research breakthroughs. If you have previously subscribed to receive email communications, your preferences have been updated.
